Medical Weight Loss

A Clinical Approach to Weight Loss

Weight loss is personal, and effective treatment requires more than willpower. At Auveau, we offer medically supervised weight management programs that combine FDA-approved GLP-1 receptor agonist medications with individualized care plans. Our providers assess your metabolic health, medication history, and goals before recommending any protocol. Every patient is different. Some respond best to different types of GLP1s. Dosing is titrated gradually under clinical supervision, with regular check-ins to monitor progress, manage side effects, and adjust your plan as your body responds. This is not a prescription mill — it is medicine practiced with the same precision we bring to every aesthetic treatment.

How GLP-1 Medications Work

GLP-1 receptor agonists mimic a hormone your body naturally produces after eating. They work through multiple mechanisms: slowing gastric emptying so you feel full longer, reducing appetite signals in the brain, and improving insulin sensitivity. The result is reduced hunger, smaller portion sizes, and more stable blood sugar throughout the day. These medications were originally developed for type 2 diabetes management and have been FDA-approved for chronic weight management in patients with a BMI of 30 or above, or 27 or above with at least one weight-related health condition. Clinical trials have demonstrated average weight loss of 15 to 22 percent of body weight over 68 weeks, depending on the medication and dosing.

Medications We Offer

We prescribe FDA-approved GLP-1 medications based on your individual health profile, insurance coverage, and clinical response. Our providers are experienced with the full range of available options and will guide you to the one that fits best.

What to Expect

Your weight loss journey at Auveau begins with a comprehensive consultation. We review your medical history, current medications, lab work, and lifestyle factors. If a GLP-1 medication is appropriate, we start at the lowest effective dose and schedule regular follow-ups — typically every four weeks during the titration phase. Most patients notice reduced appetite within the first one to two weeks. Meaningful weight loss typically becomes visible within four to six weeks. We monitor your progress, adjust dosing as needed, and provide guidance on nutrition and activity that supports your results long term. Common early side effects include mild nausea, which typically resolves as your body adjusts to the medication. Our providers are experienced in managing these transitions and will work with you to keep the process comfortable.

Why Choose Auveau for Weight Loss

What sets our program apart is the relationship. You are not a number in a telehealth queue. You see the same providers who know your history, understand your goals, and can coordinate your weight loss program with other wellness services like hormone replacement therapy or body contouring treatments like Emsculpt NEO to optimize your results. We also understand that weight loss changes your body composition in ways that may benefit from aesthetic support. Patients who lose significant weight sometimes seek skin tightening, body sculpting, or facial volume restoration as part of their transformation. Having everything under one roof, with providers who understand the full picture, means better outcomes and more coordinated care.